藥物非臨床毒性試驗(yàn)周?chē)窠?jīng)系統(tǒng)（peripheral nervous system，PNS）組織病理學(xué)評(píng)估分為4種情況：未知或預(yù)期無(wú)神經(jīng)毒性的一般毒性試驗(yàn)、可能有軀體神經(jīng)毒性的一般毒性試驗(yàn)、可能有自主神經(jīng)病的一般毒性試驗(yàn)以及預(yù)期有神經(jīng)毒性作用的專(zhuān)門(mén)神經(jīng)毒性試驗(yàn)。美國(guó)毒性病理學(xué)會(huì)（Society of Toxicologic Pathology，STP）推薦最佳實(shí)踐建議的目的是確保在藥物非臨床一般毒性試驗(yàn)和專(zhuān)門(mén)神經(jīng)毒性試驗(yàn)的4種情況下，對(duì)PNS組織進(jìn)行一致性、高效率取材、處理和評(píng)估。綜述了PNS解剖的基本結(jié)構(gòu)、PNS毒性試驗(yàn)情況分類(lèi)及取材建議、PNS毒性試驗(yàn)不同情況下最佳實(shí)踐建議、PNS神經(jīng)病理學(xué)評(píng)估分析策略以及評(píng)估結(jié)果的記錄，以期為我國(guó)藥物非臨床毒性試驗(yàn)中周?chē)窠?jīng)系統(tǒng)組織病理學(xué)評(píng)估提供一定參考。

There are four different situations encountered in histopathology assessment of peripheral nervous system (PNS) during nonclinical toxicity studies, consisted of general toxicity studies where neurotoxicity is unknown or not anticipated, general toxicity studies where somatic PNS neurotoxicity is suspected, general toxicity studies where autonomic PNS neuropathy is suspected, and dedicated neurotoxicity studies where a neurotoxic effect is expected. Current best practice recommendations of the US Society of Toxicologic Pathology (STP) are designed to ensure consistent and efficient sampling, processing and evaluating of PNS tissues for the four different situations. The basic structure of PNS anatomy, different situations and recommendations for sampling of the PNS during toxicity studies, best practice recommendations for different situations of the PNS during toxicity studies, strategy for PNS neuropathology analysis, as well as neuropathology documentation are reviewed in the paper, in order to provide some references for histopathology assessment of PNS during nonclinical toxicity studies of drugs in China.

江蘇省新藥一站式高效非臨床評(píng)價(jià)公共服務(wù)平臺(tái)建設(shè)項(xiàng)目（BM2021002）